Tilray stock is up 3.6% this morning, August 13, ahead of Tilray’s (NASDAQ:TLRY) eagerly awaited Q2 earnings announcement.
Investors appear to be somewhat optimistic ahead of the announcement, especially considering Tilray stock has been underperforming when compared with some of its competitors. Tilray shares have fallen over 40% in 2019 so far, and despite a slumping cannabis market this year, rival companies such as Canopy Growth (TSX:WEED) (NYSE:CGC) and Cronos Group (TSX:CRON) (NASDAQ:CRON) are up over 20% in the year to date.
What Can We Expect from Tilray’s Earnings?In its Q1 earnings, Tilray ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.